CASI Pharmaceuticals, Inc (DE)
CASIDelisted- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000895051
CASI Pharmaceuticals, Inc (DE) was delisted in 2023; its insiders filed their last Form 4 on Sep 9, 2022; 23 institutions reported holding it in 13F filings for Q4 2022, worth $3.31M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding CASI Pharmaceuticals, Inc (DE) changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 59 | 1 | 51 | −7 |
| Shares | 38.7M | 7.97M | 28.0M | −2.74M (−8.9%) |
| Value | $46.0M | $9.49M | $22.4M | −$14.2M (−38.8%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held CASI Pharmaceuticals, Inc (DE) at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Franklin Resources Inc | 360,900 | $289.0K | 0.00% |
| Anson Funds Management LP | 267,507 | $214.0K | 0.03% |
| RBF Capital, LLC | 159,367 | $127.0K | 0.01% |
| Two Sigma Securities, LLC | 88,667 | $71.0K | 0.01% |
| Two Sigma Advisers, LP | 83,200 | $67.0K | 0.00% |
| Two Sigma Investments, LP | 63,400 | $51.0K | 0.00% |
| Jane Street Group, LLC | 53,416 | $43.0K | 0.00% |
| Atom Investors LP | 33,891 | $27.0K | 0.01% |
| Ground Swell Capital, LLC | 18,638 | $15.0K | 0.09% |
| Selective Wealth Management, Inc. | 5 | $0 | 0.00% |
Sold out (17)
Institutions that held CASI Pharmaceuticals, Inc (DE) at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Consonance Capital Management LP | 1,563,003 | $1.86M |
| Ghost Tree Capital, LLC | 650,000 | $774.0K |
| Ergoteles LLC | 286,153 | $341.0K |
| Cubist Systematic Strategies, LLC | 218,428 | $260.0K |
| Price T Rowe Associates Inc | 87,500 | $104.0K |
| 1492 Capital Management LLC | 78,762 | $94.0K |
| HRT Financial LP | 65,353 | $77.0K |
| XTX Topco Ltd | 41,324 | $49.0K |
| Bridgeway Capital Management, LLC | 33,399 | $40.0K |
| Schonfeld Strategic Advisors LLC | 19,600 | $24.0K |
| Manatuck Hill Partners, LLC | 15,090 | $18.0K |
| Qube Research & Technologies Ltd | 10,512 | $13.0K |
| Barclays PLC | 9,757 | $12.0K |
| Wealthspire Advisors, LLC | 10,000 | $12.0K |
| Meeder Asset Management Inc | 4,073 | $5.00K |
| Total Clarity Wealth Management, Inc. | 2,000 | $2.00K |
| Joseph P. Lucia & Associates, LLC | 1 | $0 |
Not filed for Q4 2021 yet (1)
Institutions that held CASI Pharmaceuticals, Inc (DE) at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $9.49M |